PATENT CLAIM ANALYSIS

Application Number: 15745615
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "567000"]

Abstract:
The present invention relates to stabilized liquid formulations of Levothyroxine or a pharmaceutically acceptable salt thereof, intended for parenteral administration. Further this invention also describes process of preparing such compositions.

Claim (Index 5):
A stable, liquid parenteral pharmaceutical formulation of Levothyroxine comprising\n (i) Levothyroxine sodium (ii) sodium iodide (iii) cyclodextrin (iv) arginine (v) one or more solvents selected from water, propylene glycol ethanol, polyethylene glycol and glycerine.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15366864', '15700258', '15750068', '12160292', '14946947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7518350738357269
- 35 USC 102 Novelty (BERT): 0.4970622567349205
- Combined Prediction Score: 0.7263577921256462
- Mean Citation Score: 219.44458
- Max Citation Score: 251.2581
- Similarity Product: 190.8348168381572

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test